Purchase Order 36C25626P0131
- Not listed
- Novocure Inc., a foreign-owned medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 12 on October 27, 2025, for the rental of cancer treatment devices to support immediate medical needs for veteran patients. The contract, valued at $49,748.73, calls for a three-month rental period with an ultimate completion date of January 27, 2026, and will be performed at the VA facility in...
- Novocure Inc. has been awarded a $49,748.73 firm fixed-price delivery order by the Department of Veterans Affairs Veterans Integrated Service Network 12 for medical devices, with an ultimate completion date of November 15, 2025. The award was issued on October 16, 2025, and does not utilize a set-aside designation. Novocure serves as the prime contractor with no subcontractors involved, delivering its services to Portsmouth, New Hampshire. This delivery order is issued under Novocure's...
- This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, for the provision of its Optune Plus transducers and related support services. The contract, valued at $16,582.91, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) through its Veterans Integrated Service Network (VISN) 10. It is a delivery order under Novocure's $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which...
- This federal contract award was issued by the Veterans Integrated Service Network 2 (VISN 2), which is part of the Department of Veterans Affairs (VA) Veterans Health Administration (VHA), to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $33,165.82 firm-fixed-price purchase order is for the delivery of transducer products and is not associated with a set-aside designation. Novocure is the prime contractor and sole provider of the products and services under this...
- This federal contract award was made by the Veterans Integrated Service Network 17 (VISN 17), which is part of the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA), to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm fixed-price purchase order is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The...
- The Department of Veterans Affairs, Veterans Integrated Service Network 15 (VISN 15), awarded a $49,748.73 firm fixed-price purchase order to Novocure Inc. on October 30, 2025, for the rental of Optune Plus transducers. The contract, with an ultimate completion date of March 31, 2026, will be performed in Portsmouth, New Hampshire. Novocure Inc., a foreign-owned medical device manufacturer specializing in Tumor Treating Fields (TTFields) technology, will provide non-invasive cancer treatment...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded Novocure Inc., a foreign-owned for-profit organization, a firm fixed-price purchase order contract valued at $126,000.00. The contract is to provide Novocure's Optune Plus Transducer system, including device rentals and support services, for a period from November 11, 2021 to May 10, 2022. The order was issued by the VA's Veterans Integrated Service Network 15 (VISN 15) and will support the delivery of...
- This federal contract award, with an ID of 36C24225P0975, was made by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The $49,748.73 firm fixed-price purchase order is for the delivery of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat glioblastoma, mesothelioma, and other solid tumor cancers. This contract does not have a...
- This federal contract award, valued at $16,582.91, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 (VISN 8) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract is for the procurement of Optune Plus Transducers, which are part of Novocure's Optune system that utilizes Tumor Treating Fields (TTFields) technology to treat glioblastoma, mesothelioma, and other solid tumor cancers in a non-invasive manner. The...
- This federal contract award to Novocure Inc., a foreign-owned medical device manufacturer, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under a 5-year Federal Supply Schedule (FSS) contract with a ceiling value of $28.85 million. The specific award is a $16,582.91 firm-fixed-price delivery order for Novocure's Optune Plus transducers, device rentals, and associated support services. This contract supports the VA's mission of expanding...
Novocure Inc. was awarded a $49,748.73 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 16, a civilian agency under the Department of Veterans Affairs, with an ultimate completion date of January 30, 2026. The contract, awarded on October 30, 2025, covers surgical implants to be delivered to Portsmouth, New Hampshire. This award was not issued under a set-aside designation and represents a direct procurement from the prime contractor with no subcontractors involved. The award is issued under Novocure's existing Federal Supply Schedule contract (FSS-65-II-A) valued at $28.85 million for Medical Equipment and Supplies, which runs through October 31, 2027, and enables VA medical centers nationwide to access the company's Optune Tumor Treating Fields (TTFields) therapy products. Novocure Inc. is a foreign-owned medical device manufacturer specializing in non-invasive cancer treatment technologies, with FDA-approved devices for treating conditions such as glioblastoma and mesothelioma. Through its established relationship with the VA Veterans Health Administration, Novocure has consistently delivered innovative cancer therapy devices and support services to veteran patients across multiple VISNs. This purchase order represents a continuation of the company's role as a critical provider of cutting-edge medical technologies to VA facilities, delivering proprietary devices and associated support services directly to support the department's mission of expanding veterans' access to advanced treatment options.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.7k | 10/30/25 |